Choosing between Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting for Patients with Multivessel Disease: What Can We Learn from the Arterial Revascularization Therapy Study (ARTS)?

Circulation

Volumn 109, Issue 9, 2004, Pages 1079-1081

  Berger, Peter B ^a   Sketch Jr , Michael H ^a   Califf, Robert M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bypass; Coronary disease; Focused Perspectives; Revascularization; Stents

Indexed keywords

RAPAMYCIN;

CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; CORONARY STENT; DRUG ELUTING STENT; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REIMBURSEMENT; RESTENOSIS; REVIEW; STENT; VEIN GRAFT;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; COST-BENEFIT ANALYSIS; DRUG DELIVERY SYSTEMS; HUMANS; MYOCARDIAL REVASCULARIZATION; RANDOMIZED CONTROLLED TRIALS; STENTS;

EID: 1542409917     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000121313.22131.41     Document Type: Review

References (21)

1. RITA Trial Participants. Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet. 1993;343:573-580.
2. Rodriguez A, Boullon F, Perez-Balino N, et al, on behalf of the ERACI Group. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. J Am Coll Cardiol. 1993;22:1060-1067.
3. CABRI Trial Participants. First-year results of CABRI (Coronary Angioplasty vs. Bypass Revascularization Investigation). Lancet. 1995;346:1179-1184.
4. King SB III, Lembo NJ, Weintraub WS. A randomized trial comparing the coronary angioplasty with coronary bypass surgery. N Engl J Med. 1994;331:1044-1050.
5. Hamm CW, Reimers J, Ischinger T, et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med. 1994;331:1037-1043.
6. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996;335:217-225.
7. Zhang Z, Mahoney EM, Stables RH, et al. Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: one-year results from the Stent Or Surgery trial. Circulation. 2003;108:1694-1700.
8. Favarato D, Hueb W, Gersh BJ, et al. Relative cost comparison of treatments for coronary artery disease: the first year follow-up of MASS II study. Circulation. 2003;108(suppl II)II-21-II-23.
9. Rodriguez A, Bernardi V, Navia J, et al. Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30 day and one-year follow-up results. J Am Coll Cardiol. 2001;37:51-58.
10. Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344:1117-1124.
11. Morrison DA, Sethi G, Sacks J, et al, for the Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. J Am Coll Cardiol. 2001;38:143-149.
12. Serruys PW, Van Hout B, Bonnier H, et al. Randomized comparison of implantation of heparin coated stents with balloon angioplasty in selected patients with coronary artery disease. Lancet. 1998;352:673-681.
13. Legrand VMG, Serruys PW, Unger F, et al. Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. Circulation. 2004;109:1114-1120.
14. Moses JW, Leon MB, Popma JJ, et al, for the SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-1323.
15. Extended clinical trial results and registry data show durable safety and efficacy for drug eluting stents, even in the "real" world. Heartwire. Available at: http://www.theheart.org. Accessed February 20, 2004.
16. Berger PB, Alderman EL, Nadel A, et al. Frequency of early occlusion and stenosis in the left internal mammary artery among patients undergoing CABG through a median stemotomy on conventional bypass: benchmark for the MIDCAB. Circulation. 1999;100:2353-2358.
17. de Canniere D, Jansens JL, Goldschmidt-Clermont P, et al. Combination of minimally invasive coronary bypass and percutaneous transluminal coronary angioplasty in the treatment of double-vessel coronary disease: two-year follow-up of a new hybrid procedure compared with "on-pump" double bypass grafting. Am Heart J. 2001;142:563-570.
18. Best PJM, Lennon R, Ting HH, et al. The impact of renal insufficiency on clinical outcomes in patients after percutaneous coronary interventions. J Am Coll Cardiol. 2002;39:1113-1119.
19. Transformation of heart care is putting specialists at odds. Wall Street Journal. September 10, 2003.
20. Zientek DM. Physician entrepreneurs, self-referral, and conflicts of interest: an overview. HEC Forum. 2003;15:111-133.
21. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy of Sciences Press; 2001.